Sacituzumab Tirumotecan (Sac-TMT)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Sacituzumab Tirumotecan (Sac-TMT), covering 2025-09-29 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer [Phase 2]